Selvita books significant European biopharma order worth up to €5 million
Selvita SA (SLV) says it received a significant order from a European biopharmaceutical company worth up to €5 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.